Bristol-Myers Squibb: UNGC Communication on Progress
 

Bristol-Myers Squibb UN Global Compact Communication on Progress 2012

United Nations Global Compact Logo
Bristol-Myers Squibb is a participant of the United Nations Global Compact, which is the world’s largest corporate citizenship and sustainability initiative.

To Our Stakeholders

I am pleased to submit Bristol-Myers Squibb’s second annual Communication on Progress report.

Our company continues to maintain a strong commitment to the Ten Principles of the United Nations Global Compact. In fact, these principles, which are fully aligned with our overall company mission, drive our approach to good corporate citizenship and sustainability. They guide our employees. They inform our decisions. They help ensure our success.

In this annual Communication on Progress, we discuss this commitment and describe our progress to further integrate the Global Compact principles into our business strategy, daily operations and culture. This information will also be shared with our stakeholders in the course of ongoing communications.

Bristol-Myers Squibb is a company rooted in a firm commitment to the highest standards of business integrity and ethics. We therefore not only embrace the values of the United Nations Global Compact. We live them.

Sincerely,

Lamberto Andreotti
Chief Executive Officer


Introduction

Bristol-Myers Squibb joined the U.N. Global Compact in December 2010. We take this responsibility seriously and worked this year to further implement its principles encompassing Human Rights, Labor, Environment and Anti-Corruption across our company. Several significant actions were taken as a result. We communicated our commitment to the U.N. Global Compact both internally to all employees and externally to the public on our company website. We used the U.N. Global Compact Self-Assessment Tool to identify opportunities for improvement. We developed and issued a Human Rights Policy and communicated it to our employees worldwide. The Standards of Business Conduct and Ethics which govern employee actions were updated and re-issued to all employees. A Corporate Disclosure Statement on the California Transparency in Supply Chains Act regarding efforts to address slavery and human trafficking was developed and posted on our company web site. Bristol-Myers Squibb was the first pharmaceutical company to sign a joint pledge with UNAIDS and GBCHealth opposing air travel bans by some countries on HIV positive patients. Our companywide Environment, Health and Safety Management System was updated and re-issued.

We further integrated our Standards of Business Conduct and Ethics for Third Parties (3P), and added the standards to our contract language with suppliers as contracts were renewed. The 3P Standards are part of Bristol-Myers Squibb’s supplier qualification process and all of the company’s suppliers are expected to agree and abide by them. Our Chief Executive Officer has communicated on the 3P Standards to all managers and above, including employees with responsibility for supply chain management. The 3P Standards were translated into 21 languages and posted on the company web site. Our participation in the Pharmaceutical Supply Chain Initiative promotes similar Principles for Responsible Supply Chain Management among our suppliers and a joint audit pilot program was begun. We also collected environmental goals and Carbon Disclosure Project metrics from a number of our key suppliers.

Our company's website contains further information on policies, goals and progress relevant to the U.N. Global Compact, as well as our Sustainability and Corporate Social Responsibility programs. These resources include our Sustainability Report, which follows the format of the Global Reporting Initiative (GRI), with measurement of outcomes related to various performance indicators and targets. Below is a list of the U.N. Global Compact principles and a table that identifies the relevant content from our website.

Human Rights

  • Principle 1 - Businesses should support and respect the protection of internationally proclaimed human rights
  • Principle 2 - Make sure that they are not complicit in human rights abuses

Labor

  • Principle 3 - Businesses should uphold freedom of association and effective recognition of the right to collective bargaining
  • Principle 4 - The elimination of all forms of forced and compulsory labor
  • Principle 5 - The effective abolition of child labor
  • Principle 6 - Eliminate discrimination in respect of employment and occupation

Environment

  • Principle 7 - Businesses should support a precautionary approach to environmental challenges
  • Principle 8 - Undertake initiatives to promote greater environmental responsibility
  • Principle 9 - Encourage the development and diffusion of environmentally friendly technologies

Anti-Corruption

  • Principle 10 - Businesses should work against all forms of corruption, including extortion and bribery.

Bristol-Myers Squibb Website References
Human Rights
Labor
Environment
Anti-Corruption
Responsibility Message from CEO
Our Mission and Commitment
Our Standards of Business Conduct and Ethics
Our Standards of Business Conduct and Ethics for Third Parties
Sustainability Report GRI Index
Workplace Policies
Our Suppliers
Diversity & Inclusion
Social Progress
Bristol-Myers Squibb Foundation
Sustainability 2015 Goals
Achievements
Our Employees
Management Approach
Environment, Health and Safety Policy
Management Systems
Sustainability Goals and Key Indicators
Environmental Performance
Go Green
Corporate Governance
Our Compliance and Ethics Code of Conduct for U.S. Pharmaceuticals
Counterfeit Drugs
Human Rights Policy
Human Rights Statement
California Transparency in Supply Chains Act
 
 
 
 


You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.